INTEGRATED BIOPHARMA INC (INBP)

0.18 -5.26% (-0.01)

Over 1M: +12.5%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

0.14 0.16 0.18
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q4 '21 — Revenue: 17.1M Q4 '21 — Operating Cash Flow: 712K Q4 '21 — Free Cash Flow: 567K Q4 '21 — Net Income: 4.5M Q1 '22 — Revenue: 12.8M Q1 '22 — Operating Cash Flow: 2.1M Q1 '22 — Free Cash Flow: 2M Q1 '22 — Net Income: 516K Q2 '22 — Revenue: 14.6M Q2 '22 — Operating Cash Flow: -1.4M Q2 '22 — Free Cash Flow: -1.6M Q2 '22 — Net Income: 1M Q3 '22 — Revenue: 15.6M Q3 '22 — Operating Cash Flow: 675K Q3 '22 — Free Cash Flow: 532K Q3 '22 — Net Income: 797K Q4 '22 — Revenue: 13.3M Q4 '22 — Operating Cash Flow: 2.7M Q4 '22 — Free Cash Flow: 2.7M Q4 '22 — Net Income: 1.5M Q1 '23 — Revenue: 12.3M Q1 '23 — Operating Cash Flow: 992K Q1 '23 — Free Cash Flow: 942K Q1 '23 — Net Income: -35K Q2 '23 — Revenue: 12.3M Q2 '23 — Operating Cash Flow: -44K Q2 '23 — Free Cash Flow: -76K Q2 '23 — Net Income: -55K Q3 '23 — Revenue: 13.1M Q3 '23 — Operating Cash Flow: 1.5M Q3 '23 — Free Cash Flow: 1.5M Q3 '23 — Net Income: 16K Q4 '23 — Revenue: 13M Q4 '23 — Operating Cash Flow: -1.2M Q4 '23 — Free Cash Flow: -1.2M Q4 '23 — Net Income: 40K Q1 '24 — Revenue: 12.9M Q1 '24 — Operating Cash Flow: 1.3M Q1 '24 — Free Cash Flow: 1.3M Q1 '24 — Net Income: -59K Q2 '24 — Revenue: 11.5M Q2 '24 — Operating Cash Flow: -1.8M Q2 '24 — Free Cash Flow: -1.9M Q2 '24 — Net Income: -382K Q3 '24 — Revenue: 13.1M Q3 '24 — Operating Cash Flow: 1.6M Q3 '24 — Free Cash Flow: 1.3M Q3 '24 — Net Income: 285K Q4 '24 — Revenue: 12.7M Q4 '24 — Operating Cash Flow: -186K Q4 '24 — Free Cash Flow: -332K Q4 '24 — Net Income: 268K Q1 '25 — Revenue: 13.6M Q1 '25 — Operating Cash Flow: 657K Q1 '25 — Free Cash Flow: 601K Q1 '25 — Net Income: 259K Q2 '25 — Revenue: 12.6M Q2 '25 — Operating Cash Flow: 201K Q2 '25 — Free Cash Flow: 172K Q2 '25 — Net Income: 116K Q3 '25 — Revenue: 13.9M Q3 '25 — Operating Cash Flow: 616K Q3 '25 — Free Cash Flow: 500K Q3 '25 — Net Income: 611K Q4 '25 — Revenue: 14.2M Q4 '25 — Operating Cash Flow: 591K Q4 '25 — Free Cash Flow: 581K Q1 '26 — Revenue: 12.7M Q1 '26 — Operating Cash Flow: 1.3M Q1 '26 — Free Cash Flow: 1.1M Q1 '26 — Net Income: 123K Q2 '26 — Revenue: 11.3M Q2 '26 — Operating Cash Flow: 617K Q2 '26 — Free Cash Flow: 593K Q2 '26 — Net Income: -762K Q3 '26 — Revenue: 10.1M Q3 '26 — Operating Cash Flow: 517K Q3 '26 — Free Cash Flow: 517K Q3 '26 — Net Income: -837K 0 4M 8M 12M 16M 20M
Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-03-31, reported in USD. The newest fact in the filings is dated 2026-03-31, 152 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.7
SBC / sales 0.38%
OE margin 5.5%
Oper. margin -2.6%
ROIC -7.4%
Accruals -8.3%
FCF margin 5.9%
ROA 3.0%
OCF margin 6.3%
ROE 4.3%
ROCE -5.9%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.7
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -10.3×
Cash / Debt 45.9×
Debt / Eq 0.0067×
Debt payback 0.0 yr
F-score 7.9 pts
Payout 0.0%
Quick ratio 1.8×
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -9.7%
EPS Y/Y +614.6%
Shares change +0.96%
Sales Q/Q -27.5%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.